Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EBIT Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 44.64-14.6481.56139.20-22.38

What is the latest EBIT Growth ratio of NEULAND LABORATORIES ?

The latest EBIT Growth ratio of NEULAND LABORATORIES is 44.64 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202644.64
Mar2025-14.64
Mar202481.56
Mar2023139.20
Mar2022-22.38

How is EBIT Growth of NEULAND LABORATORIES Trending?

Years EBIT Growth % Change
Mar2026 44.64
Positive
Mar2025 -14.64
Negative
Mar2024 81.56
-41.41
Mar2023 139.2
Positive
Mar2022 -22.38 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EBIT Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹24,284.5 Cr -5.5% -15.2% 20.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 0.2% 6% -2.4% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-5.5%

-15.2%

20.7%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses